Cite
HARVARD Citation
Hantel, C. et al. (2016). TNF alpha signaling is associated with therapeutic responsiveness to vascular disrupting agents in endocrine tumors. Molecular and cellular endocrinology. pp. 87-95. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hantel, C. et al. (2016). TNF alpha signaling is associated with therapeutic responsiveness to vascular disrupting agents in endocrine tumors. Molecular and cellular endocrinology. pp. 87-95. [Online].